San Antonio, TX, United States of America

Lee F Kolakowski, Jr

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lee F Kolakowski, Jr. Retrieved from https://idiyas.com/inventor/lee-f-kolakowski-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lee F Kolakowski, Jr: Innovator in Nucleic Acid Research

Introduction

Lee F Kolakowski, Jr. is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of molecular biology, particularly in the study of galanin receptors. His work has implications for various medical treatments, including obesity and cognitive disorders.

Latest Patents

Lee F Kolakowski, Jr. holds a patent for a nucleic acid encoding the mouse galanin receptor (GALR2). This patent describes a new galanin receptor, GALR2, and provides nucleic acids encoding the same. Additionally, it outlines various assays to identify ligands specific to this receptor. The ligands identified through this research are useful for treating obesity, pain, and cognitive disorders.

Career Highlights

Throughout his career, Lee has focused on advancing the understanding of galanin receptors and their potential therapeutic applications. His innovative approach has led to the development of new methodologies in receptor research.

Collaborations

Lee has collaborated with Carina P Tan, contributing to the advancement of research in their field. Their partnership has fostered a productive environment for scientific discovery.

Conclusion

Lee F Kolakowski, Jr. is a distinguished inventor whose work on the GALR2 receptor has the potential to impact the treatment of various health conditions. His contributions to molecular biology continue to pave the way for future innovations in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…